IRIS Institutional Research Information System - OPENBS Open Archive UniBS

PIANTONI, SILVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.363
AS - Asia 1.248
EU - Europa 1.202
SA - Sud America 225
AF - Africa 36
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.082
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.314
SG - Singapore 499
CN - Cina 331
IT - Italia 256
DE - Germania 217
BR - Brasile 190
HK - Hong Kong 149
PL - Polonia 139
FI - Finlandia 125
VN - Vietnam 96
UA - Ucraina 95
GB - Regno Unito 83
FR - Francia 75
RU - Federazione Russa 61
TR - Turchia 40
IE - Irlanda 33
SE - Svezia 32
CA - Canada 27
BD - Bangladesh 22
IN - India 22
NL - Olanda 22
ZA - Sudafrica 13
JP - Giappone 12
AR - Argentina 11
IQ - Iraq 11
MX - Messico 11
ES - Italia 10
AT - Austria 9
PK - Pakistan 9
CO - Colombia 8
SA - Arabia Saudita 8
ID - Indonesia 7
MK - Macedonia 7
BE - Belgio 6
CZ - Repubblica Ceca 6
GR - Grecia 6
KR - Corea 6
PH - Filippine 6
AU - Australia 5
MA - Marocco 5
TN - Tunisia 5
AZ - Azerbaigian 4
EG - Egitto 4
JO - Giordania 4
KE - Kenya 4
PT - Portogallo 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
CH - Svizzera 3
DO - Repubblica Dominicana 3
EC - Ecuador 3
LT - Lituania 3
VE - Venezuela 3
BG - Bulgaria 2
BO - Bolivia 2
CL - Cile 2
CR - Costa Rica 2
ET - Etiopia 2
EU - Europa 2
IL - Israele 2
KG - Kirghizistan 2
KZ - Kazakistan 2
MY - Malesia 2
NI - Nicaragua 2
PS - Palestinian Territory 2
PY - Paraguay 2
UY - Uruguay 2
UZ - Uzbekistan 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
CY - Cipro 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
IS - Islanda 1
JM - Giamaica 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
MZ - Mozambico 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
UG - Uganda 1
Totale 5.082
Salva come PNG Salva come JPEG
Città #
Ashburn 301
Singapore 285
Fairfield 222
San Jose 167
Hong Kong 147
Warsaw 136
Woodbridge 118
New York 98
Chandler 91
Seattle 90
Beijing 89
Houston 89
The Dalles 85
Cambridge 84
Helsinki 84
Jacksonville 79
Wilmington 76
Dallas 70
Munich 63
Princeton 58
Los Angeles 45
Ann Arbor 44
Brescia 38
Lauterbourg 34
Turku 33
Dublin 32
Ho Chi Minh City 32
Istanbul 30
Milan 27
Hanoi 24
São Paulo 23
San Francisco 21
Redondo Beach 19
Buffalo 18
Council Bluffs 18
London 16
Moscow 16
Shanghai 16
Des Moines 15
Orem 14
San Diego 13
Santa Clara 13
Bergamo 12
Nanjing 12
Chicago 11
Denver 11
Johannesburg 11
Brooklyn 10
Changsha 10
Nuremberg 10
Rome 10
Tokyo 10
Montreal 9
Nanchang 8
Salò 8
Stockholm 8
Amsterdam 7
Atlanta 7
Chennai 7
Dhaka 7
Vienna 7
Belo Horizonte 6
Boardman 6
Brussels 6
Ferrara 6
Frankfurt am Main 6
Shenyang 6
Turin 6
Vancouver 6
Albuquerque 5
Bogotá 5
Erbil 5
Haikou 5
Jiaxing 5
Lappeenranta 5
Ningbo 5
Nürnberg 5
Paris 5
Rio de Janeiro 5
Amman 4
Ankara 4
Baku 4
Bosio 4
Cairo 4
Columbus 4
Dong Ket 4
Dosso 4
Guangzhou 4
Hebei 4
Jakarta 4
Jinan 4
Mexico City 4
Nairobi 4
Ninh Bình 4
Olomouc 4
Osasco 4
Redwood City 4
Rivoli 4
Seoul 4
State College 4
Totale 3.330
Salva come PNG Salva come JPEG
Nome #
9A.07: CARDIOVASCULAR TARGET ORGAN DAMAGE IN PREMENOPAUSAL SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS AND IN CONTROLS. ARE THERE ANY DIFFERENCES? 339
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study 215
Decreased circulating t regulatory lymphocytes in obese patients undergoing bariatric surgery 195
Effector T-cells are expanded in systemic lupus erythematosus patients with high disease activity and damage indexes 187
Relationship Between Different Subpopulations of Circulating CD4+ T-lymphocytes and Microvascular Structural Alterations in Humans 185
Cardiovascular target organ damage in premenopausal systemic lupus erythematosus patients and in controls: Are there any differences? 180
Prevalence and disease-specific risk factors for Lower Urinary Tract symptoms in Systemic Sclerosis: an international multi-centric study 179
Autoantibodies' titre modulation by anti-BlyS treatment in systemic lupus erythematosus. 173
Anti-carbamylated protein antibodies as a clinical response predictor in rheumatoid arthritis patients treated with abatacept 173
Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome 171
Association Between Changes in BLyS Levels and the Composition of B and T Cell Compartments in Patients With Refractory Systemic Lupus Erythematosus Treated With Belimumab 168
Relationship between different subpopulations of circulating CD4+ T lymphocytes and microvascular or systemic oxidative stress in humans 167
The limited cutaneous form of systemic sclerosis is associated with urinary incontinence: an international multicentre study 156
Anti-inflammatory action of colchicine in hospitalised patients with COVID-19. Response to: 'Colchicine treatment in community healthcare setting to prevent severe COVID-19' by Della-Torre et al 149
Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome 148
Circulating follicular helper T cells (CD4+CXCR5+ICOS+) decrease in patients with rheumatoid arthritis treated with abatacept 138
Characterization of B- and T-Cell Compartment and B-Cell Related Factors Belonging to the TNF/TNFR Superfamily in Patients With Clinically Active Systemic Lupus Erythematosus: Baseline BAFF Serum Levels Are the Strongest Predictor of Response to Belimumab after Twelve Months of Therapy. 134
Predictive factors of abatacept therapy discontinuation in patients with rheumatoid arthritis 131
Bridging the Diagnostic Gap for Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders: Evidence of a Common Extracellular Matrix Fragmentation Pattern in Patient Plasma as a Potential Biomarker 126
Pathophysiological role and therapeutic implications of vitamin d in autoimmunity: Focus on chronic autoimmune diseases 118
The rationale for the use of colchicine in COVID-19: comments on the letter by Cumhur Cure M et al 117
A Narrative Review of Pathogenetic and Histopathologic Aspects, Epidemiology, Classification Systems, and Disease Outcome Measures in Systemic Sclerosis 117
Coagulation dysfunction in COVID-19: The interplay between inflammation, viral infection and the coagulation system 116
Frequency of positive antiphospholipid antibodies in pregnant women with SARS-CoV-2 infection and impact on pregnancy outcome: A single-center prospective study on 151 pregnancies 113
Why not to use colchicine in COVID-19? An oldanti-inflammatory drug for a novel auto-inflammatory disease 112
The Influence of Treatment of Inflammatory Arthritis During Pregnancy on the Long-Term Children's Outcome. 109
CXCL-13 serum levels in patients with rheumatoid arthritis treated with abatacept 93
Pregnancy in antiphospholipid syndrome: what should a rheumatologist know? 90
Reply to: Anti-carbamylated protein antibodies are associated with early abatacept response in rheumatoid arthritis by Castellanos-Moreira et al 90
Regulation of neutrophil associated RNASET2 expression in rheumatoid arthritis 89
Calprotectin as a biomarker in rheumatoid arthritis: the potential predictive value of response to treatment 89
Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome 81
The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus 81
Endothelial Dysfunction in Systemic Lupus Erythematosus and Systemic Sclerosis: A Common Trigger for Different Microvascular Diseases 76
Undifferentiated connective tissue disease: the diagnoses critically revised-experience of a single center 74
Multiparametric autoantibody analysis: a new paradigm for the diagnosis of connective tissue diseases 67
Response to: 'Correspondence on 'Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome'' by Kawada 67
Editorial: Into the heart of systemic autoimmune diseases. 64
Urinary incontinence in systemic sclerosis: a prospective multicentre cohort study 56
Diagnostic performance of particle-based multi-analyte technology compared to indirect immunofluorescence in screening for anti-nuclear antibodies in patients with autoimmune rheumatic diseases 15
Potential role of the spleen in the development of arterial hypertension in humans 11
Multicenter study to improve clinical interpretation of anticardiolipin and anti-β2-glycoprotein I antibody test results for diagnosis of antiphospholipid syndrome 6
Totale 5.165
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.737
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.737
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202170 0 0 0 0 0 0 0 0 0 0 36 34
2021/2022321 26 24 9 29 3 26 14 17 15 51 44 63
2022/2023250 33 8 7 19 27 62 3 28 46 0 7 10
2023/2024419 23 11 57 44 22 82 12 63 60 6 2 37
2024/2025933 9 19 21 110 71 83 57 54 96 94 181 138
2025/20261.836 176 229 145 235 197 153 297 85 97 175 47 0
Totale 5.165